The opportunity for AR / VR based digital marketing service providers in healthcare

Roots Analysis has announced the addition of “AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030” report to its list of offerings.

Over time, various pharma players have taken advantage of these immersive technologies for education, training as well as marketing, purposes. These technologies have been demonstrated to be capable of driving better customer engagement, and generating useful insights based on their expectations and purchase behaviors. Given the increasing demand for immersive technologies in the healthcare and pharma marketing, several stakeholders are expected to forge alliances with AR / VR service providers in the foreseen future. Owing to the rising interest of big pharma players in this domain, we expect an escalated industry-wide adoption of such technologies.

To order this 180+ page report, which features 45+ figures and 70+ tables, please visit AR / VR based Healthcare Digital Marketing Service Providers Market, 2020-2030

Key Market Insights

More than 125 companies claim to offer different AR / VR based digital marketing services to the healthcare and pharma industry.
The majority of players engaged in providing AR / VR based digital marketing services to the healthcare and pharmaceutical industry are small-sized companies (63%), followed by mid-sized (32%) and large players (5%). In addition, majority (38%) of the players were established during the period 2011-2015.

Several big pharma players have taken significant strides in in the field of AR / VR
These instances are either by collaborating with digital marketing service providers or through development of in-house capabilities. Majority (18%) of the instances were recorded in the year 2018.

More than 350 industry players have been identified as likely partners for AR / VR based digital marketing service providers
The potential strategic partners have been identified by evaluating more than 4,500 industry sponsored clinical trials (including phase I / II

Leave a Reply

Your email address will not be published. Required fields are marked *